A Trial on the Efficacy, Safety and Immunogenicity of Live-Attenuated Influenza Vaccine (LAIV)

NCT02964065 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

9000

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Live-Attenuated influenza Vaccine(LAIV)
BIOLOGICAL: Placebo

Sponsor

Changchun BCHT Biotechnology Co.

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]